RTA 408 in the Treatment of Advanced Solid Tumors (NSCLC & Melanoma) - DISCOVER

NCT02029729 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic or Incurable Non-small Cell Lung Cancer
Relapsed, Refractory Melanoma

Interventions

DRUG: omaveloxolone

Sponsor

Biogen

Collaborators

[object Object]